NASDAQ : PYXS
Pyxis Oncology, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 1.89 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 225.77M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Pyxis Oncology, Inc. (PYXS) reported revenue of 11.04M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 11.04M | 13.86M | 16.15M | |||
| Cost of Revenue | 2.39M | 2.39M | 475.00K | |||
| Gross Profit | 8.65M | 11.47M | 15.67M | |||
| Selling, General & Admin | 22.80M | 19.62M | 22.49M | 30.83M | 37.35M | 18.66M |
| Research & Development | 75.56M | 73.70M | 58.75M | 49.59M | 86.13M | 51.05M |
| Operating Expenses | 98.36M | 93.31M | 81.24M | 80.42M | 123.48M | 69.72M |
| Operating Income | -89.71M | -81.84M | -65.57M | -80.42M | -123.48M | -69.72M |
| Interest & Investment Income | 2.09M | 3.61M | 7.04M | 6.63M | 2.76M | 23.00K |
| Earnings From Equity Investments | -231.00K | |||||
| Other Non Operating Income (Expenses) | -6.05M | |||||
| EBT Excluding Unusual Items | -87.62M | -78.23M | -58.53M | -73.79M | -120.72M | -75.97M |
| Pretax Income | -87.62M | -78.23M | -79.50M | -73.79M | -120.72M | -75.97M |
| Income Tax Expense | 1.10M | 1.39M | -2.16M | |||
| Net Income | -88.73M | -79.62M | -77.33M | -73.79M | -120.72M | -75.97M |
| Net Income to Common | -88.73M | -79.62M | -77.33M | -73.79M | -120.72M | -75.97M |
| Shares Outstanding (Basic) | 63.25M | 62.14M | 58.45M | 39.90M | 33.03M | 8.49M |
| Shares Outstanding (Diluted) | 63.25M | 62.14M | 58.45M | 39.90M | 33.03M | 8.49M |
| EPS (Basic) | -1.40 | -1.28 | -1.32 | -1.85 | -3.65 | -8.95 |
| EPS (Diluted) | -1.40 | -1.28 | -1.32 | -1.85 | -3.65 | -8.95 |
| Free Cash Flow | -67.92M | -63.51M | -57.91M | -77.44M | -95.73M | -35.87M |
| Free Cash Flow Per Share | -1.07 | -1.02 | -0.99 | -1.94 | -2.90 | -4.22 |
| Gross Margin | 78.37% | 82.77% | 97.06% | |||
| Operating Margin | -812.74% | -590.60% | -406.11% | |||
| Profit Margin | -803.83% | -574.55% | -478.95% | |||
| Free Cash Flow Margin | -615.32% | -458.30% | -358.66% | |||
| EBITDA | -85.53M | -77.33M | -62.59M | -78.49M | -122.77M | -69.07M |
| D&A For EBITDA | 4.18M | 4.51M | 2.98M | 1.93M | 709.00K | 647.00K |
| EBIT | -89.71M | -81.84M | -65.57M | -80.42M | -123.48M | -69.72M |
| Revenue as Reported | 13.86M | 13.86M | 16.15M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 18.86M | 15.42M | 19.47M | 9.66M | 179.29M | 274.74M |
| Short-Term Investments | 14.14M | 51.44M | 107.46M | 109.63M | ||
| Cash & Short-Term Investments | 33.00M | 66.86M | 126.93M | 119.30M | 179.29M | 274.74M |
| Other Receivables | 700.00K | 598.00K | ||||
| Receivables | 700.00K | 598.00K | ||||
| Prepaid Expenses | 2.27M | 586.00K | 761.00K | 1.01M | 1.31M | 1.76M |
| Restricted Cash | 1.47M | 1.47M | 1.47M | 1.47M | 1.47M | 1.47M |
| Other Current Assets | 2.49M | 3.28M | 2.82M | 3.94M | 703.00K | |
| Total Current Assets | 36.73M | 72.11M | 132.44M | 124.60M | 186.61M | 278.67M |
| Property, Plant & Equipment | 18.19M | 19.41M | 22.14M | 24.81M | 24.77M | 1.24M |
| Other Intangible Assets | 2.60M | 24.31M | ||||
| Other Long-Term Assets | 109.00K | |||||
| Total Assets | 54.92M | 91.52M | 157.18M | 173.73M | 211.38M | 280.02M |
| Accounts Payable | 3.27M | 10.88M | 4.86M | 3.90M | 7.10M | 11.95M |
| Accrued Expenses | 12.38M | 8.12M | 10.73M | 12.62M | 23.45M | 6.33M |
| Current Portion of Leases | 1.82M | 1.69M | 1.45M | 1.23M | 165.00K | |
| Current Unearned Revenue | 7.66M | |||||
| Other Current Liabilities | 10.00M | 431.00K | 643.00K | 356.00K | 1.09M | 266.00K |
| Total Current Liabilities | 27.47M | 21.13M | 17.68M | 25.76M | 31.63M | 18.71M |
| Long-Term Leases | 16.01M | 16.98M | 18.75M | 20.10M | 18.92M | |
| Long-Term Deferred Tax Liabilities | 2.16M | |||||
| Total Liabilities | 43.48M | 38.11M | 36.43M | 48.02M | 50.55M | 18.71M |
| Common Stock | 63.00K | 63.00K | 60.00K | 45.00K | 34.00K | 32.00K |
| Additional Paid-In Capital | 503.18M | 496.47M | 484.08M | 411.82M | 373.23M | 353.00M |
| Retained Earnings | -491.80M | -443.18M | -363.56M | -286.23M | -212.44M | -91.72M |
| Comprehensive Income & Other | -4.00K | 53.00K | 170.00K | 63.00K | ||
| Total Common Equity | 11.44M | 53.41M | 120.75M | 125.70M | 160.82M | 261.31M |
| Shareholders' Equity | 11.44M | 53.41M | 120.75M | 125.70M | 160.82M | 261.31M |
| Total Liabilities & Equity | 54.92M | 91.52M | 157.18M | 173.73M | 211.38M | 280.02M |
| Total Debt | 17.83M | 18.67M | 20.20M | 21.33M | 18.92M | 165.00K |
| Net Cash (Debt) | 15.16M | 48.18M | 106.73M | 97.97M | 160.37M | 274.57M |
| Net Cash Per Share | 0.24 | 0.78 | 1.83 | 2.46 | 4.85 | 32.33 |
| Filing Date Shares Outstanding | 83.41M | 62.83M | 61.59M | 58.13M | 36.83M | 32.22M |
| Total Common Shares Outstanding | 63.43M | 62.69M | 59.97M | 44.75M | 34.96M | 32.17M |
| Working Capital | 9.26M | 50.97M | 114.76M | 98.84M | 154.98M | 259.96M |
| Book Value Per Share | 0.18 | 0.85 | 2.01 | 2.81 | 4.60 | 8.12 |
| Tangible Book Value | 11.44M | 53.41M | 118.15M | 101.40M | 160.82M | 261.31M |
| Tangible Book Value Per Share | 0.18 | 0.85 | 1.97 | 2.27 | 4.60 | 8.12 |
| Machinery | 4.15M | 4.19M | 4.52M | 3.28M | 1.90M | |
| Construction In Progress | 9.18M | |||||
| Leasehold Improvements | 10.74M | 10.74M | 10.96M | 530.00K | 225.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -88.73M | -79.62M | -77.33M | -73.79M | -120.72M | -75.97M |
| Depreciation & Amortization | 4.18M | 4.51M | 2.98M | 1.93M | 709.00K | 647.00K |
| Asset Writedown & Restructuring Costs | 20.96M | 9.28M | 20.00M | |||
| Loss (Gain) From Sale of Investments | -1.34M | -2.96M | -6.11M | -4.79M | ||
| Loss (Gain) on Equity Investments | 50.00K | |||||
| Stock-Based Compensation | 11.89M | 11.80M | 12.95M | 16.95M | 15.76M | 6.44M |
| Other Operating Activities | 896.00K | 824.00K | 700.00K | 660.00K | 1.13M | 6.83M |
| Change in Accounts Payable | -6.14M | 6.03M | 1.20M | -3.51M | -8.33M | 4.64M |
| Change in Unearned Revenue | -7.66M | 998.00K | ||||
| Change in Other Net Operating Assets | 8.33M | -4.08M | -3.20M | -9.15M | 12.83M | 2.03M |
| Operating Cash Flow | -67.91M | -63.50M | -57.67M | -70.71M | -89.33M | -35.33M |
| Capital Expenditures | -9.00K | -9.00K | -237.00K | -6.73M | -6.40M | -540.00K |
| Cash Acquisitions | 6.66M | |||||
| Investment in Securities | 65.41M | 58.87M | 8.39M | -104.78M | -50.00K | |
| Investing Cash Flow | 65.40M | 58.86M | 8.15M | -104.85M | -6.40M | -590.00K |
| Issuance of Common Stock | 10.79M | 742.00K | 51.87M | 6.37M | 183.00K | 152.46M |
| Repurchase of Common Stock | -157.00K | -148.00K | -240.00K | -445.00K | ||
| Other Financing Activities | 7.70M | |||||
| Financing Cash Flow | 10.63M | 594.00K | 59.33M | 5.93M | 183.00K | 304.04M |
| Net Cash Flow | 8.12M | -4.05M | 9.81M | -169.63M | -95.55M | 268.13M |
| Free Cash Flow | -67.92M | -63.51M | -57.91M | -77.44M | -95.73M | -35.87M |
| Free Cash Flow Margin | -615.32% | -458.30% | -358.66% | |||
| Free Cash Flow Per Share | -1.07 | -1.02 | -0.99 | -1.94 | -2.90 | -4.22 |
| Levered Free Cash Flow | -23.19M | -31.38M | -33.79M | -43.21M | -57.39M | -25.47M |
| Unlevered Free Cash Flow | -23.19M | -31.38M | -33.79M | -43.21M | -57.39M | -25.47M |
| Cash Interest Paid | 91.00K | 91.00K | 10.00K | 1.00K | ||
| Cash Income Tax Paid | 1.38M | 1.38M | 164.00K | 48.00K | 17.00K | |
| Change in Working Capital | 5.18M | 1.94M | -11.82M | -11.66M | 4.50M | 6.68M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 216.22M | 71.60M | 92.77M | 79.75M | 46.70M | 353.33M |
| Enterprise Value | 201.05M | 14.42M | -31.51M | -31.60M | -135.79M | 414.21M |
| Last Close Price | 1.81 | 1.15 | 1.56 | 1.80 | 1.34 | 10.97 |
| PS Ratio | 19.59 | 5.17 | 5.75 | |||
| PB Ratio | 10.04 | 1.34 | 0.77 | 0.63 | 0.29 | 1.35 |
| P/TBV Ratio | 18.90 | 1.34 | 0.79 | 0.79 | 0.29 | 1.35 |
| EV/Sales Ratio | 18.21 | 1.04 | ||||
| Debt / Equity Ratio | 1.56 | 0.35 | 0.17 | 0.17 | 0.12 | 0.00 |
| Net Debt / Equity Ratio | -1.33 | -0.90 | -0.88 | -0.78 | -1.00 | -1.05 |
| Net Debt / EBITDA Ratio | 0.18 | 0.62 | 1.71 | 1.25 | 1.31 | 3.98 |
| Net Debt / FCF Ratio | 0.22 | 0.76 | 1.84 | 1.26 | 1.68 | 7.66 |
| Asset Turnover | 0.12 | 0.11 | 0.10 | |||
| Quick Ratio | 1.20 | 3.20 | 7.18 | 4.63 | 5.69 | 14.69 |
| Current Ratio | 1.34 | 3.41 | 7.49 | 4.84 | 5.90 | 14.90 |
| Return on Equity (ROE) | -179.10% | -91.44% | -62.76% | -51.51% | -57.19% | -56.78% |
| Return on Assets (ROA) | -62.95% | -41.14% | -24.77% | -26.10% | -31.41% | -30.03% |
| Return on Capital Employed (ROCE) | -326.80% | -116.30% | -47.00% | -54.30% | -68.70% | -26.70% |
| Earnings Yield | -77.51% | -111.20% | -83.36% | -92.53% | -258.50% | -21.50% |
| FCF Yield | -31.41% | -88.70% | -62.42% | -97.10% | -205.00% | -10.15% |
| Buyback Yield / Dilution | -3.27% | -6.33% | -46.46% | -20.80% | -288.93% | -724.14% |